AstraZeneca Starts New COVID-19 Prevention Trials Of Antibody Cocktail

AstraZeneca started latestage trials on Saturday of an experimental longacting monoclonal antibody combination drug it hopes could be used as a socalled prophylactic to prevent COVID19 infection in atrisk people for up to 12 months.

from Top World News- News18.com https://ift.tt/2UIMELk